CLASP2 p.Thr478Ser
c.1433C>G · rs752250877 · VCV2484561
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5726 | likely pathogenic |
|---|---|---|
| REVEL | 0.272 | benign-leaning |
| SaProt | LLR -7.12 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.62 | unconstrained · MANE · 38 kb · p 8.3e-12 · regional, not allelic |
| Overall | ||
| CADD | 26.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM T245S vs ClinVar T478S) — verify the residue.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CLASP2
- Protein
- p.Thr478Ser
- Coding
- c.1433C>G
- MANE Select
- NM_001365631
- dbSNP
- rs752250877
- Type
- single nucleotide variant
- Location
- chr3:33608582 (GRCh38)
- Gene constraint
- LOEUF 0.365 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 66.98 · 7 PDB
- Residue 478
- the 'interaction with microtubules, mapre1 and mapre3' region; a modified residue (phosphoserine)
Similar variants
- CLASP2 p.Thr478Ile Uncertain significance ★ ⚠ same residue
- CLASP2 c.1949-9C>T Benign ★★ same type
- CLASP2 p.Gly57= Benign ★★ same type
- CLASP2 p.Ser544= Benign ★★ same type
- CLASP2 c.2068+1G>A Uncertain significance ★ same type
- CLASP2 c.2455-1137A>C Uncertain significance ★ same type
- CLASP2 p.Ala1209Gly Uncertain significance ★ ⚠ same type
- CLASP2 p.Ala1251Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/clasp2-p-thr478ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown